Sichuan Hebang Biotechnology Corporation Limited
603077.SS · SHH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -CN¥70,745 | CN¥1,278,699 | CN¥3,810,239 | CN¥3,031,337 |
| Dep. & Amort. | CN¥992,187 | CN¥1,002,474 | CN¥929,598 | CN¥643,933 |
| Deferred Tax | CN¥0 | CN¥0 | -CN¥28,438 | CN¥97,641 |
| Stock-Based Comp. | CN¥0 | CN¥0 | CN¥506,485 | CN¥0 |
| Change in WC | -CN¥613,723 | -CN¥2,202,595 | -CN¥2,177,769 | -CN¥543,518 |
| Other Non-Cash | CN¥160,212 | CN¥122,181 | -CN¥395,852 | CN¥64,966 |
| Operating Cash Flow | CN¥467,931 | CN¥80,332 | CN¥2,644,263 | CN¥3,196,718 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -CN¥1,116,226 | -CN¥828,735 | -CN¥936,181 | -CN¥1,735,052 |
| Net Acquisitions | CN¥0 | CN¥91,131 | CN¥4,000 | CN¥17,905 |
| Inv. Purchases | -CN¥283,780 | -CN¥165,049 | CN¥0 | -CN¥57,484 |
| Inv. Sales/Matur. | CN¥29,330 | CN¥120,427 | CN¥62,286 | CN¥51,822 |
| Other Inv. Act. | -CN¥16,443 | -CN¥120,428 | CN¥62,653 | CN¥334 |
| Investing Cash Flow | -CN¥1,387,119 | -CN¥902,654 | -CN¥807,242 | -CN¥1,722,475 |
| Financing Activities | – | – | – | – |
| Debt Repay. | CN¥6,489,857 | CN¥147,110 | CN¥459,304 | -CN¥808,000 |
| Stock Issued | -CN¥1,245 | CN¥0 | CN¥668,693 | CN¥179,928 |
| Stock Repurch. | -CN¥1,196,789 | -CN¥500,370 | -CN¥668,693 | -CN¥179,928 |
| Dividends Paid | -CN¥246,664 | -CN¥463,603 | -CN¥197,827 | -CN¥77,981 |
| Other Fin. Act. | -CN¥197,949 | -CN¥197,705 | CN¥743,506 | CN¥446,546 |
| Financing Cash Flow | CN¥4,847,210 | -CN¥943,597 | CN¥1,004,984 | -CN¥619,364 |
| Forex Effect | CN¥18,709 | CN¥5,465 | CN¥21,856 | -CN¥10,554 |
| Net Chg. in Cash | CN¥3,946,731 | -CN¥1,640,026 | CN¥2,863,860 | CN¥844,326 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | CN¥2,904,832 | CN¥4,544,858 | CN¥1,680,998 | CN¥836,672 |
| End Cash | CN¥6,851,563 | CN¥2,904,832 | CN¥4,544,858 | CN¥1,680,998 |
| Free Cash Flow | -CN¥648,295 | -CN¥748,404 | CN¥1,708,081 | CN¥1,461,667 |